Trials / Completed
CompletedNCT02503085
Ibuprofen Suspension Bioequivalence Study
A Randomized, Single-dose, 4-way Crossover, Open-label, Pharmacokinetic (PK) Study Comparing a 2% (w/v) Suspension of Ibuprofen (400 mg/20 mL Nurofen for Children®) With a Swiss Reference 2% (w/v) Suspension of Ibuprofen (400 mg/20 mL Algifor Dolo Junior®) in the Fed and Fasted States
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Reckitt Benckiser Healthcare (UK) Limited · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to determine the rate and extent of absorption of Ibuprofen suspension formulations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nurofen for Children® | |
| DRUG | Algifor Dolo Junior® |
Timeline
- Start date
- 2015-06-02
- Primary completion
- 2015-08-25
- Completion
- 2015-08-25
- First posted
- 2015-07-20
- Last updated
- 2018-04-13
- Results posted
- 2018-04-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02503085. Inclusion in this directory is not an endorsement.